Orion Oyj (ORNBV.HE)
HELSINKI, Oct 21 - Finnish drug maker Orion reported a third-quarter operating profit down 4 percent from a year earlier reflecting increased competition from generic drug makers.
Sept 22 - Orion Oyj : * Orion announces amended settlement agreement over the proprietary drug
Earnings vs. Estimates
Analyst Research Reports
Orion Oyj: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.